International Journal of Drug Policy
Volume 21, Issue 3 , Pages 244-246, May 2010

Methamphetamine use among gay men across the UK

  • Christopher P. Bonell

      Affiliations

    • Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 020 7927 2145; fax: +44 020 7580 4524.
  • ,
  • Ford C.I. Hickson

      Affiliations

    • Sigma Research, University of Portsmouth, 77a Tradescant Road, London SW8 1XJ, United Kingdom
  • ,
  • Peter Weatherburn

      Affiliations

    • Sigma Research, University of Portsmouth, 77a Tradescant Road, London SW8 1XJ, United Kingdom
  • ,
  • David S. Reid

      Affiliations

    • Sigma Research, University of Portsmouth, 77a Tradescant Road, London SW8 1XJ, United Kingdom

Received 31 March 2009; received in revised form 23 July 2009; accepted 29 July 2009. published online 03 September 2009.

Abstract 

Background

Concerns about gay men's methamphetamine use reflect its physical and psychological harms, and association with sexual-risk behaviour and HIV infection. Existing research suggests gay men's use in the UK is low and may be largely confined to London.

Methods

Cross-sectional survey of convenience sample of UK gay men.

Results

Methamphetamine was used by a significant minority of gay men in London but also in other regions. Overall, use was highest among those men aged 30–49, HIV-positive and reporting sexual-risk behaviours.

Conclusion

Methamphetamine was used by a significant minority of gay men in and outside London. Targeted prevention and treatment services should be developed and evaluated.

Keywords: Homosexual, HIV, Methamphetamine, Street drugs, Sexual behaviour

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(09)00109-1

doi:10.1016/j.drugpo.2009.07.002

International Journal of Drug Policy
Volume 21, Issue 3 , Pages 244-246, May 2010